| Literature DB >> 17636477 |
Sebastien Kairouz1, Jana Hashash, Wadih Kabbara, Wassim McHayleh, Imad A Tabbara.
Abstract
Dendritic cell neoplasms are rare tumors that are being recognized with increasing frequency. They were previously classified as lymphomas, sarcomas, or histiocytic neoplasms. The World Health Organization (WHO) classifies dendritic cell neoplasms into five groups: Langerhans' cell histiocytosis, Langerhans' cell sarcoma, Interdigitating dendritic cell sarcoma/tumor, Follicular dendritic cell sarcoma/tumor, and Dendritic cell sarcoma, not specified otherwise (Jaffe, World Health Organization classification of tumors 2001; 273-289). Recently, Pileri et al. provided a comprehensive immunohistochemical classification of histiocytic and dendritic cell tumors (Pileri et al., Histopathology 2002;59:161-167). In this article, a concise overview regarding the pathological, clinical, and therapeutic aspects of follicular dendritic, interdigitating dendritic, and Langerhans' cell tumors is presented.Entities:
Mesh：
Substances：
Year: 2007 PMID： 17636477 DOI： 10.1002/ajh.20857
Source DB: PubMed Journal: Am J Hematol ISSN： 0361-8609 Impact factor: 10.047